Kilitch Drugs (India) Ltd (KILITCH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 189669,
    "name": "Kilitch Drugs",
    "stock_name": "Kilitch Drugs",
    "full_name": "Kilitch Drugs (India) Ltd",
    "name_url": "stocks-analysis/kilitch-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "196.00",
    "chg": 2.45,
    "chgp": "1.27%",
    "dir": 1,
    "prev_price": "193.55",
    "mcapval": "692.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524500,
    "symbol": "KILITCH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE729D01010",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "14.86 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/kilitch-drugs-189669-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kilitch Drugs Upgraded to Hold as Financial and Technical Trends Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-upgraded-to-hold-as-financial-and-technical-trends-improve-4002096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_mojoScore_4002096.png",
        "date": "2026-05-21 08:01:16",
        "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement across financial performance, valuation metrics, and technical indicators. The company’s recent quarterly results and evolving market trends have contributed to a more balanced outlook, signalling cautious optimism for investors in this pharmaceuticals micro-cap."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-4002010",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_technicaldot_4002010.png",
        "date": "2026-05-21 08:00:26",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 5.8% daily gain to ₹184.15, coupled with a significant upgrade in its Mojo Grade from Sell to Hold, signals a cautious optimism among investors amid mixed market conditions."
      },
      {
        "title": "Kilitch Drugs Valuation Shifts to Attractive Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-valuation-shifts-to-attractive-amid-market-volatility-3997659",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_valuationdot_3997659.png",
        "date": "2026-05-19 08:00:14",
        "description": "Kilitch Drugs (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential inflection point for investors. With its price-to-earnings (P/E) ratio easing to 19.44 and price-to-book value (P/BV) at 2.10, the pharmaceutical company is now trading at more compelling levels relative to its historical averages and peer group, despite a recent 10.88% surge in its share price."
      },
      {
        "title": "Kilitch Drugs Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3988480",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_mojoScore_3988480.png",
        "date": "2026-05-13 08:00:51",
        "description": "Kilitch Drugs (India) Ltd has been downgraded from a Sell to a Strong Sell rating as of 12 May 2026, reflecting deteriorating technical indicators and disappointing financial performance. The micro-cap pharmaceutical company’s Mojo Score has fallen to 26.0, signalling heightened risk for investors amid a challenging market environment and weak operational metrics."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-faces-bearish-momentum-amid-technical-downturn-3988432",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KilitchDrugsInd_technicaldot_3988432.png",
        "date": "2026-05-13 08:00:44",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating moving averages and mixed signals from momentum oscillators, paints a challenging outlook for investors amid a micro-cap pharmaceutical sector environment."
      }
    ],
    "total": 15,
    "sid": "189669",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/kilitch-drugs-india-189669"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Aug-2026",
      "details": "We are submitting herewith the copy of the newspaper publication of extract of AGM Notice",
      "source": "BSE"
    },
    {
      "caption": "Notice Of Annual General Meeting",
      "datetime": "01-Aug-2026",
      "details": "We are hereby submitting the notice of Annual General Meeting schedule to be held on Thursday 27th August 2026",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "01-Aug-2026",
      "details": "We are submitting herewith the annual report for the FY 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19",
          "dt": "2019-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Mar 26",
          "dt": "2026-03-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Kilitch Drugs Upgraded to Hold as Financial and Technical Trends Improve

2026-05-21 08:01:16

Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement across financial performance, valuation metrics, and technical indicators. The company’s recent quarterly results and evolving market trends have contributed to a more balanced outlook, signalling cautious optimism for investors in this pharmaceuticals micro-cap.

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-21 08:00:26

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 5.8% daily gain to ₹184.15, coupled with a significant upgrade in its Mojo Grade from Sell to Hold, signals a cautious optimism among investors amid mixed market conditions.

Kilitch Drugs Valuation Shifts to Attractive Amid Market Volatility

2026-05-19 08:00:14

Kilitch Drugs (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential inflection point for investors. With its price-to-earnings (P/E) ratio easing to 19.44 and price-to-book value (P/BV) at 2.10, the pharmaceutical company is now trading at more compelling levels relative to its historical averages and peer group, despite a recent 10.88% surge in its share price.

Kilitch Drugs Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-05-13 08:00:51

Kilitch Drugs (India) Ltd has been downgraded from a Sell to a Strong Sell rating as of 12 May 2026, reflecting deteriorating technical indicators and disappointing financial performance. The micro-cap pharmaceutical company’s Mojo Score has fallen to 26.0, signalling heightened risk for investors amid a challenging market environment and weak operational metrics.

Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn

2026-05-13 08:00:44

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating moving averages and mixed signals from momentum oscillators, paints a challenging outlook for investors amid a micro-cap pharmaceutical sector environment.

View All News